Rigel Pharmaceuticals Inc (RIGL)
$51.31 -0.27% Close Oct 30, 2026 Live
Rigel Pharmaceuticals stock today
Rigel Pharmaceuticals closed at $51.31 on October 30, 2026, down 0.27% on the day. Over the past year it returned +62.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $949 million.
$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | RIGL | S&P 500 (SPY) |
|---|---|---|
| 1 month | +6.6% | -0.9% |
| 3 months | +34.8% | +2.1% |
| Year to date | +19.8% | +11.7% |
| 1 year | +62.3% | +12.4% |
| 3 years | +557.5% | +88.5% |
| 5 years | +52.7% | +76.0% |
Key statistics
- Market value
- $949M
- P/E (trailing)
- 3.0
- Forward P/E
- 12.1
- Price / sales
- 3.4
- 52-week range
- $25.44 to $51.45
- Next report
- Nov 5, 2026
About Rigel Pharmaceuticals
Develops and commercializes pharmaceutical therapies for immune and inflammatory diseases.
Sector: Health Care
More on Rigel Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +64% in the year to Dec 2025
- Valuation: P/E history and peersP/E 3.0
- Returns: what $1,000 became$1,000 ten years ago is $1,981 today
No forecast, no recommendation. This page describes Rigel Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.